Rebecca G Bechhold MD
Breast Cancer, Hematologic Oncology, Hospice & Palliative
Associate Clinical Professor Medical University of South Carolina
Join to view full profile
171 Ashley AveCharleston, SC 29425
Phone+1 843-792-1414
Dr. Bechhold is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rebecca Bechhold is an oncologist in Charleston, SC. She received her medical degree from University of Louisville School of Medicine and has been in practice 39 years. She specializes in breast cancer, hematologic oncology, and hospice & palliative and is experienced in breast cancer, lung cancer, hospice and palliative care.
Education & Training
University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 1981 - 1983
University of Cincinnati1979 - 1981- University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1978 - 1981
University of CincinnatiPGY I, 1978 - 1979
University of Louisville School of MedicineClass of 1978
Certifications & Licensure
SC State Medical License 2012 - 2027
FL State Medical License 2005 - 2024
OH State Medical License 1979 - 2017
KY State Medical License 1997 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012, 2014-2015
- CMS Meaningful Use Stage 1 Certification IntelliDose, IntrinsiQ Specialty Solutions, Inc. FBO Healthtronics Information Technology Solutions Inc., 2012, 2014-2015
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 48 citationsA phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response ...Denise A. Yardley, N. W. Peacock, Mythili Shastry, Howard A. Burris, Rebecca Bechhold
Breast Cancer Research and Treatment. 2015-10-27 - 3 citationsNeoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Operable Breast Cancer: A Phase II Trial of the Sarah Cannon Research InstituteDenise A. Yardley, John D. Zubkus, Janice F. Eakle, Rebecca Bechhold, L Finney
Clinical Breast Cancer. 2015-08-01 - 143 citationsEMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast CancerDenise A. Yardley, Robert Weaver, Michelle E. Melisko, Mansoor N. Saleh, Francis P. Arena
Journal of Clinical Oncology. 2015-05-10
Authored Content
- Treading Water in the Information TsunamiJuly 2018
- Treading Water in the Information TsunamiJuly 2018
- Treading Water in the Information TsunamiJuly 2018
Professional Memberships
- Member
Industry Relationships
- Speakers Bureau, Novartis2006 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
